Authors:
SAIVIN S
CARRIE D
ESCOURROU J
DUCHENE P
ZAMBONI V
BARBANTI M
PALAZZINI E
HOUIN G
Citation: S. Saivin et al., PHARMACOKINETICS OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE (DESMIN) INDIFFERENT COHORTS OF PATIENTS, Thrombosis research, 90(3), 1998, pp. 139-145
Authors:
MIGLIOLI M
PIRONI L
RUGGERI E
SERRA C
ZAMBONI V
BARBANTI M
CANOVA N
CALANNI F
MILANI MR
PALAZZINI E
Citation: M. Miglioli et al., BIOAVAILABILITY OF DESMIN, A LOW-MOLECULAR-WEIGHT DERMATAN SULFATE, AFTER SUBCUTANEOUS ADMINISTRATION TO HEALTHY-VOLUNTEERS, International journal of clinical & laboratory research, 27(3), 1997, pp. 195-198
Authors:
PACETTI P
GARAU D
CARAMATTI C
MANGONI L
ZAMBONI V
CANOVA N
RIZZOLI V
Citation: P. Pacetti et al., ASSESSMENT OF THE EFFICACY OF A LAST-GENERATION POLYVALENT IMMUNOGLOBULIN IN THE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA, Current medical research and opinion, 13(9), 1997, pp. 517-527
Authors:
VENOSI S
ZAMBONI V
IRACE L
STUMPO R
MASSA R
PALAZZINI E
VALENTINI FB
Citation: S. Venosi et al., EFFICACY OF AN INTRAVENOUS LOW-MOLECULAR-WEIGHT DERMATAN SULFATE (DESMIN) IN PATIENTS WITH ACUTE PROXIMAL DEEP VENOUS THROMBOSIS AND SILENTPULMONARY-EMBOLISM - A PILOT-STUDY, Journal of international medical research, 25(2), 1997, pp. 98-107
Authors:
KRETZ JG
CHAKFE N
WIESEL ML
GRUNEBAUM L
ZAMBONI V
PALAZZINI E
CAZENAVE JP
Citation: Jg. Kretz et al., THE TREATMENT OF DEEP-VEIN THROMBOSIS WITH CONTINUOUS INTRAVENOUS LOW-MOLECULAR-WEIGHT DERMATAN SULFATE (DESMIN) - A PILOT-STUDY, Thrombosis research, 84(6), 1996, pp. 391-398
Authors:
DETTORI AG
ZAMBONI V
MANOTTI C
CANOVA N
BARBANTI M
PALAZZINI E
Citation: Ag. Dettori et al., PHARMACOLOGY OF A NEW LOW-MOLECULAR-WEIGHT DERMATAN SULFATE (DESMIN) IN HEALTHY-VOLUNTEERS - REPEATED DAILY INTRAMUSCULAR ADMINISTRATION OF400 MG FOR A WEEK, Thrombosis research, 83(1), 1996, pp. 103-109
Authors:
CATANIA G
TESAURO B
MEGHA A
SALANITRI T
CATALANO F
ROMANO G
BIGNAMINI A
ZAMBONI V
PALAZZINI E
Citation: G. Catania et al., PRELIMINARY COMPARISON OF THE CLINICAL EFFICACY AND TOLERABILITY OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE AND CALCIUM HEPARIN IN POSTTHROMBOTIC SYNDROME, Current therapeutic research, 57(12), 1996, pp. 969-979
Authors:
ANDREOZZI GM
SIGNORELLI S
DIPINO L
MARTINI R
MARCHITELLI E
PINTO A
ROMEO S
ZAMBONI V
PALAZZINI E
Citation: Gm. Andreozzi et al., TOLERABILITY AND CLINICAL EFFICACY OF DESMIN IN THE TREATMENT OF SUPERFICIAL THROMBOVARICOPHLEBITIS, Angiology, 47(9), 1996, pp. 887-894
Authors:
DETTORI AG
MILANI MR
MANOTTI C
ZAMBONI V
PALAZZINI E
BARBANTI M
Citation: Ag. Dettori et al., PHARMACOLOGY OF DESMIN (LOW-MOLECULAR-WEIGHT DERMATAN SULFATE) IN HEALTHY-VOLUNTEERS FOLLOWING INTRAVENOUS BOLUS ADMINISTRATION OF DIFFERENT DOSAGES (200, 400, 800 MG), Thrombosis research, 79(3), 1995, pp. 249-260
Authors:
TRAINI AM
CERVI V
MELANDRI G
PALAZZINI E
ZAMBONI V
SEMPRINI F
CANDIOTTI N
BRANZI A
Citation: Am. Traini et al., PHARMACODYNAMIC CHARACTERISTICS OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE AFTER SUBCUTANEOUS ADMINISTRATION IN ACUTE MYOCARDIAL-INFARCTION, Journal of international medical research, 22(6), 1994, pp. 323-331
Authors:
CUCINOTTA D
MANOPULO R
GALATI M
ZAMBONI V
PALAZZINI E
BARBANTI M
MILANI MR
Citation: D. Cucinotta et al., PHARMACODYNAMICS OF A NEW LOW-MOLECULAR-WEIGHT DERMATAN SULFATE AFTERA SINGLE SUBCUTANEOUS INJECTION IN ELDERLY PATIENTS WITH CHRONIC VENOUS DISORDERS - A PHASE-I TRIAL, Current therapeutic research, 55(12), 1994, pp. 1492-1500